Doctor profile · Federal record
Dr. STEVEN HARRIS, M.D.
Pulmonary Disease Physician (CMS: CRITICAL CARE (INTENSIVISTS)) · AUSTELL, GA
- NPI 1346248267
- Accepts Medicare
- MIPS 98.5 / 100 · 2023
- 37 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3820 MEDICAL PARK DR
AUSTELL, GA 301061110
(770) 948-6041
fax (770) 739-5411
Credentials & registration
- NPI registered
- July 2005 — 21 yrs on file
- Profile last updated
- January 21, 2016
- Year of graduation
- 1989 — 37 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Georgia #039814
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1346248267. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,217
Distinct HCPCS
10
Medicare allowed
$150,744
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
94010 |
Test to measure expiratory airflow and volume | 363 | 264 | $27 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 300 | 222 | $126 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 270 | 180 | $177 | |
71046 |
X-ray of chest, 2 views | 227 | 104 | $17 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 200 | 24 | $1 | |
96372 |
Injection of drug or substance under skin or into muscle | 155 | 36 | $14 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 105 | 98 | $90 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 86 | 53 | $120 | |
94729 |
Test to examine how well the lungs exchange gases | 75 | 70 | $57 | |
94726 |
Test to determine lung volumes using sensors | 73 | 68 | $55 |
In context: peer comparison
Among 8 peers in this city , average services per provider: 65. This provider delivers 34× the peer median.Open Payments
Industry payments received
All-time total
$2,046
Transactions
102
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $561.14 | |
| GlaxoSmithKline, LLC. | 25 | $355.49 | |
| Amgen Inc. | 13 | $184.06 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $170.84 | |
| GENZYME CORPORATION | 5 | $148.93 | |
| Regeneron Healthcare Solutions, Inc. | 7 | $140.35 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $90.08 | |
| PFIZER INC. | 5 | $84.15 | |
| Grifols USA, LLC | 4 | $78.32 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $57.48 | |
| Vifor Pharma, Inc. | 2 | $37.04 | |
| Axsome Therapeutics, Inc. | 1 | $28.49 | |
| Mallinckrodt Hospital Products Inc. | 1 | $26.73 | |
| Mylan Specialty L.P. | 1 | $24.55 | |
| Phadia US Inc. | 1 | $21.54 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,466
Patients
787
Total drug cost
$1,444,464
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 711 | 161 | $749,697 |
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 404 | 164 | $14,725 |
| Montelukast Sodium | Generic | 316 | 109 | $5,437 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 232 | 46 | $139,813 |
| Prednisone | Generic | 117 | 83 | $227 |
| Arnuity Ellipta (Fluticasone Furoate) | Brand | 113 | 33 | $52,996 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 92 | 29 | $74,455 |
| Levalbuterol Tartrate Hfa (Levalbuterol Tartrate) | Brand | 69 | 32 | $4,169 |
| Ipratropium Bromide | Generic | 63 | 23 | $2,964 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 63 | 23 | $59,445 |